enVVeno Medical (NVNO) said Monday that it has appointed Jennifer Bright as its chief financial officer, effective the same day.
The company said Bright brings over 25 years of financial and strategic experience with medical device and pharmaceutical companies such as Biolase, Spectrum Pharmaceuticals, and Teleflex Medical (TFX).
Bright succeeds Craig Glynn, who will continue to serve as an advisor to enVVeno, the company said.